MyLupusTeam

There's growing evidence that Epstein-Barr virus (EBV) may play a significant role in triggering lupus. EBV is incredibly common — about 95% of people in the U.S. have had it at some point, often with mild or no symptoms. After infection, the virus stays dormant in the body.

Researchers at Stanford Medicine found that people Show Full Answer

There's growing evidence that Epstein-Barr virus (EBV) may play a significant role in triggering lupus. EBV is incredibly common — about 95% of people in the U.S. have had it at some point, often with mild or no symptoms. After infection, the virus stays dormant in the body.

Researchers at Stanford Medicine found that people with lupus had far more immune cells (called B cells) infected with EBV. Normally, certain harmful B cells stay inactive, but EBV may "wake them up," causing them to mistakenly attack the body's own tissues — a hallmark of lupus. One senior researcher went as far as saying EBV may apply to 100% of lupus cases, which is a bold claim — but scientists are cautious to note it's likely just one piece of a larger puzzle that includes genetics, hormones, and other environmental factors.

What this means practically:

- There's no need to get tested for EBV if you have lupus
- Current lupus treatments haven't changed based on these findings
- EBV is so widespread it's nearly impossible to avoid
- Clinical trials for EBV vaccines are underway, though still early

The exciting part? This research is pointing toward a new generation of therapies that could more precisely target the immune cells involved in lupus. It's worth bringing up with your rheumatologist if you're curious how it might relate to your own situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

New Clues Show How EBV May Play a Role in Lupus